Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate 42385-0801
Product NDC
42385-0801- Manufacturer
- Laurus Labs Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 5, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA220232
Need to source Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Emtricitabine | 200 mg/1 |
| Rilpivirine Hydrochloride | 25 mg/1 |
| Tenofovir Disoproxil Fumarate | 300 mg/1 |
Drug Class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Packaging Options(1)
30 TABLET, FILM COATED in 1 BOTTLE (42385-801-30)
External Resources